Royal Bank of Canada’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-1,200
| Closed | -$1K | – | 7680 |
|
2022
Q2 | $1K | Sell |
1,200
-33
| -3% | -$27 | ﹤0.01% | 6829 |
|
2022
Q1 | $6K | Buy |
1,233
+1,200
| +3,636% | +$5.84K | ﹤0.01% | 6743 |
|
2021
Q4 | $0 | Sell |
33
-2
| -6% | – | ﹤0.01% | 7528 |
|
2021
Q3 | $0 | Sell |
35
-1,107
| -97% | – | ﹤0.01% | 7444 |
|
2021
Q2 | $19K | Buy |
1,142
+517
| +83% | +$8.6K | ﹤0.01% | 6098 |
|
2021
Q1 | $17K | Sell |
625
-196
| -24% | -$5.33K | ﹤0.01% | 6047 |
|
2020
Q4 | $30K | Buy |
821
+286
| +53% | +$10.5K | ﹤0.01% | 5341 |
|
2020
Q3 | $19K | Sell |
535
-39
| -7% | -$1.39K | ﹤0.01% | 5236 |
|
2020
Q2 | $24K | Buy |
574
+476
| +486% | +$19.9K | ﹤0.01% | 5055 |
|
2020
Q1 | $8K | Sell |
98
-1
| -1% | -$82 | ﹤0.01% | 5416 |
|
2019
Q4 | $9K | Buy |
99
+64
| +183% | +$5.82K | ﹤0.01% | 5599 |
|
2019
Q3 | $3K | Buy |
35
+2
| +6% | +$171 | ﹤0.01% | 5580 |
|
2019
Q2 | $3K | Sell |
33
-34
| -51% | -$3.09K | ﹤0.01% | 5569 |
|
2019
Q1 | $4K | Hold |
67
| – | – | ﹤0.01% | 5391 |
|
2018
Q4 | $4K | Hold |
67
| – | – | ﹤0.01% | 5403 |
|
2018
Q3 | $4K | Hold |
67
| – | – | ﹤0.01% | 5759 |
|
2018
Q2 | $3K | Buy |
67
+49
| +272% | +$2.19K | ﹤0.01% | 5622 |
|
2018
Q1 | $2K | Buy |
18
+7
| +64% | +$778 | ﹤0.01% | 5534 |
|
2017
Q4 | $2K | Buy |
+11
| New | +$2K | ﹤0.01% | 5561 |
|
2017
Q3 | – | Hold |
0
| – | – | – | 6218 |
|
2017
Q2 | – | Hold |
0
| – | – | – | 6040 |
|
2017
Q1 | – | Sell |
-6
| Closed | – | – | 6043 |
|
2016
Q4 | $0 | Hold |
6
| – | – | ﹤0.01% | 5986 |
|
2016
Q3 | $0 | Hold |
6
| – | – | ﹤0.01% | 5773 |
|
2016
Q2 | $0 | Buy |
6
+2
| +50% | – | ﹤0.01% | 5773 |
|
2016
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 5857 |
|
2015
Q4 | $1K | Sell |
4
-6
| -60% | -$1.5K | ﹤0.01% | 5745 |
|
2015
Q3 | $7K | Buy |
+10
| New | +$7K | ﹤0.01% | 5466 |
|